A new study, performed by Dr. Carlos Aguirre-Velazquez and published in Neurology Research International, suggests CBD may successfully treat refractory epilepsy in children. In the study, Dr. Aguirre-Velazquez provided structured online surveys to parents in Mexico and other areas of Latin America who were using CBD to treat their children's epilepsy. The study involved 53 epilepsy cases in children between the ages of 9 months and 18 years old, and several different forms of childhood epilepsy, including Lennox-Gastaut Syndrome, unspecified refractory epilepsy, West syndrome, Doose syndrome, and Ohtahara syndrome.
Of the 43 cases in Mexico, 51% of patients experienced a decrease in convulsions by more than 75%, while 16% of patients became seizure free. 47% of all of the cases in the study had reported previously using 9 or more anticonvulsant therapies, and when CBD was used, parents reported a decrease in convulsions in over 81% of cases. In 9 of 43 cases, the use of CBD allowed patients to reduce the number of anti-epileptic drugs involved in their therapies. No adverse side effects were reported throughout the study, with only minor side effects like increased appetite or changes in sleep pattern reported. Overall quality of life was reported, with 88% showing improved cognition, 86% showing improved emotions or moods, 77% showing improved sleep, and 67% showing improved appetite.
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.